Essure

Why Am I Hearing About a New Study on Essure When It’s No Longer In Use?

By Evita Almassi | Jul 20, 2020 | Comments Off on Why Am I Hearing About a New Study on Essure When It’s No Longer In Use?

Essure (a permanent non-hormonal, non-surgical birth control method) is no longer available in the U.S. – but many women still have the device in place, and a study of the device, mandated by the FDA is ongoing.

NWHN Statement on Halt of Essure Sales in the U.S.

By Cindy Pearson | Jul 20, 2018 | Comments Off on NWHN Statement on Halt of Essure Sales in the U.S.

FOR IMMEDIATE RELEASE Contact: Evita Almassi, [email protected] or (202) 682-2640

FDA Comments – Real World Evidence & Essure

By Shaniqua Seth | Oct 14, 2016 | Comments Off on FDA Comments – Real World Evidence & Essure

Comments on the Draft Guidance: Use of Real-World Evidence to Support Regulatory Decision Making for Medical Devices

Essure and Challenges in Contraceptive Choice

By NWHN Staff | Mar 14, 2016 | Comments Off on Essure and Challenges in Contraceptive Choice

Contraceptive needs and desires are as individual as the women who use them. All contraception should be safe and effective and not cause harm to the user; when thousands of women share stories of harm resulting from their contraception, the National Women’s Health Network (NWHN) listens.

Essure Update: FDA Warns Women About Risks

By NWHN Staff | Mar 1, 2016 | Comments Off on Essure Update: FDA Warns Women About Risks

Earlier today, the FDA announced that it is taking steps to make it easier for women considering sterilization to get reliable information about Essure, an implanted device.  The Network recommended that the FDA take these steps, and we’re pleased that they’re taking action on this important women’s health issue.

“FDA’s Actions on Essure are Steps in the Right Direction”

By Cindy Pearson | Feb 29, 2016 | Comments Off on “FDA’s Actions on Essure are Steps in the Right Direction”

NWHN Statement in Response to FDA Draft Guidance

FDA Meeting – Essure

By Cindy Pearson | Sep 24, 2015 | Comments Off on FDA Meeting – Essure

Testimony Delivered at the FDA Meeting of the Obstetrics and Gynecology Devices Panel